Revolution Medicines (RVMD) Payables (2019 - 2026)
Revolution Medicines (RVMD) reported Payables of $88.42 million for Q2 2026, up 55.8% from $56.76 million a year earlier and up 9.8% from the prior quarter.
Powered by 
Analysis
Revolution Medicines (RVMD) Payables (2019 - 2026) Analysis & Trends
At the end of FY2025, Revolution Medicines posted Payables of $64.62 million, up 18.7% from FY2024.
- Payables has a five-year compound annual growth rate of 38.7% (FY2020 to FY2025).
- By year, Payables came in at $54.43 million in FY2024 (-11.9%), $61.79 million in FY2023 (+190.0%), $21.31 million in FY2022 (+51.6%) and $14.06 million in FY2021 (+11.5%).
- The Q2 2026 figure ranks as the highest quarterly Payables in data going back to Q4 2019.
- Year over year, Payables has now increased in each of the last six quarters, with growth averaging 57.6% over the last eight quarters.
- The high point for year-over-year Payables in five years was Q3 2025 (growth of 206.1%); the low point was Q3 2024 (a decline of 17.5%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $80.54 million (Q1 2026), $64.62 million (Q4 2025) and $74.85 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,221.09 Bn | 1,194.71 Bn | 20.46 Bn | 5.79 Bn |
| 2 | Johnson & Johnson | 656.38 Bn | 576.24 Bn | 17.30 Bn | 18.17 Bn |
| 3 | AbbVie | 510.79 Bn | 478.80 Bn | 13.12 Bn | 34.43 Bn |
| 4 | Merck | 363.00 Bn | 317.38 Bn | 12.21 Bn | 5.96 Bn |
| 5 | Novartis Ag | 313.89 Bn | 287.12 Bn | - | - |
| 6 | Astrazeneca | 290.02 Bn | 263.91 Bn | 13.26 Bn | -25.19 Bn |
| 7 | Amgen | 249.59 Bn | 204.98 Bn | 7.24 Bn | 2.87 Bn |
| 8 | Gilead Sciences | 208.15 Bn | 183.26 Bn | 6.73 Bn | 934.00 Mn |
| 9 | Pfizer | 170.74 Bn | 118.10 Bn | 12.56 Bn | 4.07 Bn |
| 10 | Revolution Medicines | 38.00 Bn | 28.20 Bn | - | 88.42 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 88.42 Mn |
| Mar 31, 2026 | 80.54 Mn |
| Dec 31, 2025 | 64.62 Mn |
| Sep 30, 2025 | 74.85 Mn |
| Jun 30, 2025 | 56.76 Mn |
| Mar 31, 2025 | 47.51 Mn |
| Dec 31, 2024 | 54.43 Mn |
| Sep 30, 2024 | 24.46 Mn |
| Jun 30, 2024 | 29.32 Mn |
| Mar 31, 2024 | 32.38 Mn |
| Dec 31, 2023 | 61.79 Mn |
| Sep 30, 2023 | 29.63 Mn |
| Jun 30, 2023 | 29.78 Mn |
| Mar 31, 2023 | 19.91 Mn |
| Dec 31, 2022 | 21.31 Mn |
| Sep 30, 2022 | 24.38 Mn |
| Jun 30, 2022 | 14.07 Mn |
| Mar 31, 2022 | 14.17 Mn |
| Dec 31, 2021 | 14.06 Mn |
| Sep 30, 2021 | 10.49 Mn |
API Access
Revolution Medicines Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=payables&ticker=RVMD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "payables", "ticker": "RVMD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=payables&ticker=RVMD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();